Lamothe Jeffrey G.
SEC insider (Form 3/4/5 filer). CIK 0001679967. President and CEO at Aptevo Therapeutics Inc. (APVO). 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 6, 2026. Located in SEATTLE, WA.
Companies Lamothe Jeffrey G. has filed insider reports for
- Aptevo Therapeutics Inc. (APVO): Director, Officer, President and CEO
Lamothe Jeffrey G.
CIK: 0001679967
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)4 (80.0%)
Derivative conversions
Awards (A)1 (20.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
APVO
Aptevo Therapeutics Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 6, 2026APVO
Aptevo Therapeutics Inc.
ExerciseDirect961 shares- - Aug 6, 2025APVO
Aptevo Therapeutics Inc.
AwardDirectRestricted Stock Unit
17.3K shares- - Jul 17, 2025APVO
Aptevo Therapeutics Inc.
ExerciseDirect5 shares- - Mar 3, 2025APVO
Aptevo Therapeutics Inc.
ExerciseDirect2 shares- - Mar 2, 2025APVO
Aptevo Therapeutics Inc.
ExerciseDirect3 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 | APVO Aptevo Therapeutics Inc. | Exercise | 961 | - | $0 | Direct |
| Aug 6, 2025 | APVO Aptevo Therapeutics Inc. | Award Restricted Stock Unit | 17,300 | - | - | Direct |
| Jul 17, 2025 | APVO Aptevo Therapeutics Inc. | Exercise | 5 | - | - | Direct |
| Mar 3, 2025 | APVO Aptevo Therapeutics Inc. | Exercise | 2 | - | - | Direct |
| Mar 2, 2025 | APVO Aptevo Therapeutics Inc. | Exercise | 3 | - | - | Direct |
1-5 of 5 transactions